PE-backed firm with right to sell COVID-19 drug snags fresh capital

A Pune-based drugmaker that counts two private equity firms as investors and recently started selling a medicine to treat COVID-19 patients with mild to moderate symptoms has raised fresh debt capital. Brinton Pharmaceuticals Ltd, which is backed by India Alternatives and Tata Capital Healthcare Fund, has secured debt capital from non-banking ......